Thursday, January 19, 2023 1:51:46 AM
Whether it's angry people or hurt people, there is too much footage to post. This compilation of recent sudden deaths and critical injuries goes on for 45 minutes. How many are occurring when cameras aren't around? How long will this continue?...
https://www.bitchute.com/video/Lt6K4E5boZzh/
https://www.bitchute.com/video/Lt6K4E5boZzh/
Recent PFE News
- AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:52:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:22:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:21:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:20:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:19:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:19:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:18:19 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/27/2026 03:22:47 PM
- Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts • Business Wire • 03/24/2026 02:00:00 PM
- Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial • Business Wire • 03/23/2026 10:45:00 AM
- Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC • Business Wire • 03/20/2026 08:30:00 PM
- Pfizer’s TALZENNA combination shows progress against prostate cancer • IH Market News • 03/19/2026 02:44:13 PM
- TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer • Business Wire • 03/19/2026 10:45:00 AM
- Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer • Business Wire • 03/17/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 09:45:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/12/2026 01:12:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/12/2026 01:05:18 PM
- Pfizer shares slip despite encouraging trial results for eczema treatment • IH Market News • 03/09/2026 01:52:10 PM
- Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis • Business Wire • 03/09/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:27:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:26:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:26:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 10:26:52 PM
